Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eva‐Maria Rom‐Jurek"'
Autor:
Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, Olaf Ortmann, Anja K. Wege, Gero Brockhoff
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 2, p 563 (2018)
Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression
Externí odkaz:
https://doaj.org/article/91a9df9bd9ec498fa08700379377b36b
Autor:
Anja Kathrin Wege, Eva‐Maria Rom‐Jurek, Paul Jank, Carsten Denkert, Peter Ugocsai, Christine Solbach, Jens‐Uwe Blohmer, Bruno Sinn, Marion Mackelenbergh, Volker Möbus, Andreas Trumpp, Elisabetta Marangoni, Nicole Pfarr, Christoph Irlbeck, Jens Warfsmann, Bernhard Polzer, Florian Weber, Olaf Ortmann, Sibylle Loibl, Valentina Vladimirova, Gero Brockhoff
Publikováno v:
International journal of cancerREFERENCES. 150(8)
Estrogen receptor-positive breast cancer is a highly prevalent but heterogeneous disease among women. Advanced molecular stratification is required to enable individually most efficient treatments based on relevant prognostic and predictive biomarker
Autor:
Anja Kathrin Wege, Valentina Vladimirova, Christine Solbach, Eva-Maria Rom-Jurek, Jens-Uwe Blohmer, Paul Jank, Bruno Sinn, Andreas Trumpp, Elisabetta Marangoni, Knut Engels, Wilko Weichert, Nicole Pfarr, Christoph Irlbeck, Bernhard Polzer, Olaf Ortmann, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl, Gero Brockhoff
Publikováno v:
Cancer Research. 82:PD9-07
Background: Luminal, i.e., estrogen receptor (ER)-positive breast cancer (BC) is a heterogeneous disease in terms of tumor progression, therapy response, and relapse. Additional biomarkers with a prognostic and predictive impact would facilitate adva
Autor:
Brockhoff, Eva-Maria Rom-Jurek, Nicole Kirchhammer, Peter Ugocsai, Olaf Ortmann, Anja Wege, Gero
Publikováno v:
International Journal of Molecular Sciences; Volume 19; Issue 2; Pages: 563
Programmed death ligand 1 (PD-L1) expression is an efficient strategy of tumor cells to escape immunological eradiation. However, only little is known about the factors that affect the cellular expression levels. Here we assessed the PD-L1 expression
Autor:
Armin Kurtz, Miriam C. Banas, Claudia R.C. van Roeyen, Bernhard Banas, Simone Wurm, Andreas Steege, Eva-Maria Rom-Jurek
The homeostatic chemokine receptor CCR7 serves as key molecule in lymphocyte homing into secondary lymphoid tissues. Previous experiments from our group identified CCR7 also to be expressed by human mesangial cells. Exposing cultured human mesangial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df0551f6dab4db35b664da9ea2440dfe